ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 751605 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 751605; 2) Community: the network communities that were significantly associated with the response to NSC 751605; 3) Molecule: the relationships between components within communities and NSC 751605; 4) MDR: the compounds that were significantly associated with the NSC 751605.

NSC Compound Enrichment Correlation
NSC 658356 Null 0.0186186224062458 0.050342955
NSC 663337 Null 0.0186186224062458 0.05149535
NSC 668366 Null 0.0186186224062458 0.15215418
NSC 671660 Null 0.0186186224062458 -0.0625833
NSC 67239 as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-, triacetate 0.0186186224062458 0.3053493
NSC 677959 16.beta.-N-methylpiperazino-5-androstene-3.beta.,17.beta.-diol 0.0186186224062458 0.17647824
NSC 682298 Camptothecin Derivative 0.0186186224062458 0.2169222
NSC 683332 Spiro[2a,8a-epoxyanthra[2,3-b]oxirene- 2-(1aH),2'-naphtho[1,8-de][1,3]dioxin]-3,8(9H,9aH)-dione, 9-hydroxy-, stereoisomer 0.0186186224062458 0.2346083
NSC 687606 Null 0.0186186224062458 -0.076374612
NSC 691767 Null 0.0186186224062458 0.30520254
Total:79  Current:30    [First] [Prev] [Next] [Last]